Jiawei Shou Selected Research

Adenocarcinoma

10/2019

CircUBAP2-mediated competing endogenous RNA network modulates tumorigenesis in pancreatic adenocarcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jiawei Shou Research Topics

Disease

9	Neoplasms (Cancer) 09/2022 - 01/2015
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2021 - 01/2016
3	Lung Neoplasms (Lung Cancer) 01/2021 - 11/2015
2	Hepatocellular Carcinoma (Hepatoma) 10/2020 - 10/2014
1	Disease Progression 01/2021
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2021
1	Carcinogenesis 10/2019
1	Adenocarcinoma 10/2019
1	Squamous Cell Carcinoma of Head and Neck 01/2019

Drug/Important Bio-Agent (IBA)

2	Peptides (Polypeptides)IBA 01/2022 - 01/2020
2	ErbB Receptors (EGF Receptor)IBA 01/2021 - 01/2016
2	Tyrosine Kinase InhibitorsIBA 01/2021 - 01/2016
2	Gefitinib (Iressa)FDA Link 11/2020 - 01/2016
2	Cyclosporine (Ciclosporin)FDA LinkGeneric 11/2020 - 01/2016
2	linifanibIBA 10/2020 - 10/2014
2	Competitive Endogenous RNAIBA 10/2019 - 01/2019
1	Immune Checkpoint InhibitorsIBA 09/2022
1	Programmed Cell Death 1 ReceptorIBA 09/2022
1	16S Ribosomal RNAIBA 09/2022
1	Protein Subunit VaccinesIBA 01/2022
1	apatinibIBA 01/2021
1	anlotinibIBA 01/2021
1	atezolizumabIBA 01/2021
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2021
1	VaccinesIBA 01/2020
1	Anaplastic Lymphoma KinaseIBA 10/2019
1	MicroRNAs (MicroRNA)IBA 01/2019
1	Transcription Factors (Transcription Factor)IBA 01/2019
1	Galectin 2 (LGALS2)IBA 01/2018
1	CrizotinibIBA 11/2015
1	Protein Isoforms (Isoforms)IBA 06/2015

Therapy/Procedure

6	Therapeutics 01/2021 - 10/2014
3	Immunotherapy 09/2022 - 01/2020
1	Radiofrequency Ablation 01/2022
1	Drug Therapy (Chemotherapy) 11/2015